Koëter M, van Steenbergen L N, Lemmens V E P P, Rutten H J T, Roukema J A, Nieuwenhuijzen G A P
Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Comprehensive Cancer Centre, Eindhoven, The Netherlands.
Cancer Epidemiol. 2015 Dec;39(6):863-9. doi: 10.1016/j.canep.2015.10.007. Epub 2015 Nov 9.
Preferred treatment for resectable oesophageal cancer is surgery with or without neoadjuvant treatment. However, oesophageal surgery has high morbidity and in vulnerable patients with co-morbidity other treatment modalities can be proposed. We examined determinants in decision making for surgery and factors affecting survival in patients with resectable oesophageal cancer in southern Netherlands.
All patients with resectable (T1-3, N0-1, M0-1A) oesophageal cancer (n=849) diagnosed between 2003 and 2010 were selected from the population-based data of the Eindhoven Cancer Registry. Logistic regression analysis and multivariable Cox survival analysis were conducted to examine determinants of surgery and survival.
Forty-five percent of the patients underwent surgery. In multivariable survival analysis only surgery, chemoradiation alone and tumour stage influenced overall survival (OS). Patients aged ≥ 70 yrs, a low socioeconomic status (SES), one or more co-morbidities, cT1-tumours, cN1-tumours, a squamous-cell carcinoma, and those with a proximal tumour were significantly less often offered surgical resection. Older patients and patients with cT1 tumours were less likely to receive chemoradiation alone. Patients with clinically positive lymph nodes or a proximal tumour were more likely to receive chemoradiation alone.
Treatment modalities including surgery and chemoradiation alone as well as stage of disease were independent predictors of a better OS in patients with potentially resectable oesophageal cancer. Therefore, the decision to perform potentially curative treatment is of crucial importance to improve OS for patients with potentially resectable oesophageal cancer. Although age and SES had no significant influence on overall survival, a higher age and low SES negatively influenced the probability to propose potentially curative treatment.
可切除食管癌的首选治疗方法是手术,可联合或不联合新辅助治疗。然而,食管手术的发病率较高,对于合并症较多的脆弱患者,可以考虑其他治疗方式。我们研究了荷兰南部可切除食管癌患者手术决策的决定因素以及影响生存的因素。
从埃因霍温癌症登记处基于人群的数据中选取2003年至2010年间诊断为可切除(T1-3,N0-1,M0-1A)食管癌的所有患者(n = 849)。进行逻辑回归分析和多变量Cox生存分析以研究手术和生存的决定因素。
45%的患者接受了手术。在多变量生存分析中,只有手术、单纯放化疗和肿瘤分期影响总生存期(OS)。年龄≥70岁、社会经济地位(SES)低、有一种或多种合并症、cT1期肿瘤、cN1期肿瘤、鳞状细胞癌以及肿瘤位于近端的患者接受手术切除的可能性明显较低。老年患者和cT1期肿瘤患者接受单纯放化疗的可能性较小。临床淋巴结阳性或肿瘤位于近端的患者更有可能接受单纯放化疗。
包括手术和单纯放化疗以及疾病分期在内的治疗方式是潜在可切除食管癌患者OS改善的独立预测因素。因此,决定进行潜在的根治性治疗对于改善潜在可切除食管癌患者的OS至关重要。尽管年龄和SES对总生存期没有显著影响,但较高的年龄和较低的SES对提出潜在根治性治疗的可能性有负面影响。